FABP2 and myocardial ischemia: Specific markers for intestinal ischemic damage, as used in clinical practice for cardiac ischemia, are so far lacking and discussed candidates such as citrulline, I-FABP, and d-lactate lack sufficient discriminative ability or mandate further testing [11, 28].